SEC Probes Matrixx Following FDA Zicam Warning
The U.S. Securities and Exchange Commission has asked Matrixx Initiatives Inc. to turn over documents and information related to the U.S. Food and Drug Administration's warning that a few of the...To view the full article, register now.
Already a subscriber? Click here to view full article